Yin-Yang regulation of autoimmunity by DCs

Trends in Immunology

Volumn 25, Issue 7, 2004, Pages 353-359

  'T Hart, Bert A ^a,b   Van Kooyk, Yvette ^c  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; LECTIN RECEPTOR; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RHEUMATOID FACTOR; TOLL LIKE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; DENDRITIC CELL; GENETIC PREDISPOSITION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; RECEPTOR BINDING; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 2942685251     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.04.006     Document Type: Article

References (59)

1. Meinl E., et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am. J. Pathol. 150:1997;445-453
2. Villoslada P., et al. Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naïve outbred primates. Eur. J. Immunol. 31:2001;2942-2950
3. Iglesias A., et al. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia. 36:2001;220-234
4. Wilkin T. Autoimmunity: attack, or defence? (The case for a primary lesion theory). Autoimmunity. 3:1989;57-73
5. Wekerle H., Lassmann H. Contra: evidence against a primary lesion in the target organ in autoimmune disease. Int. Arch. Allergy Immunol. 103:1994;328-331
6. Bauer J., et al. Apoptosis in brain-specific autoimmune disease. Curr. Opin. Immunol. 7:1995;839-843
7. de Vos A.F., et al. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 169:2002;5415-5423
8. Becker K.J., et al. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10873-10878
9. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:2003;253-257
10. Jonuleit H., et al. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22:2001;394-400
11. Geijtenbeek T.B.H., et al. Self- and non-self recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22:2004;33-54
12. Figdor C.G., et al. C-type lectin receptors on dendritic cells and langerhans cells. Nat. Rev. Immunol. 2:2002;77-84
13. Akira S., et al. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680
14. Takeda K., et al. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376
15. Gantner B.N., et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:2003;1107-1117
16. Aragane Y., et al. Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J. Immunol. 171:2003;3801-3807
17. Nigou J., et al. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166:2001;7477-7485
18. Chieppa M., et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol. 171:2003;4552-4560
19. Geijtenbeek T.B., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:2003;7-17
20. van Kooyk Y., Geijtenbeek T.B.H. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3:2003;697-709
21. Brok H.P., et al. Non-human primate models of multiple sclerosis. Immunol. Rev. 183:2001;173-185
22. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 101:2003;4862-4869
23. Ardavin C., et al. Dendritic cells: immunobiology and cancer immunotherapy. Immunity. 20:2004;17-23
24. Hawiger D., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:2001;769-779
25. Ichikawa H.T., et al. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 169:2002;2781-2787
26. Daniels M.A., et al. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat. Immunol. 3:2002;903-910
27. Lowe J.B., Marth J.D. A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72:2003;643-691
28. Yamamoto M., et al. Expression profiling of 68 glycosyltransferase genes in 27 different human tissues by the systematic multiplex reverse transcription-polymerase chain reaction method revealed clustering of sexually related tissues in hierarchical clustering algorithm analysis. Electrophoresis. 24:2003;2295-2307
29. Bond A., et al. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J. Autoimmun. 10:1997;77-85
30. Alavi A., et al. Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis. Ann. Med. Interne (Paris). 149:1998;251-260
31. Bond A., et al. Post-partum flare in MRL-lpr/lpr mice is associated with a parallel increase of N-acetylglucosamine on serum IgG. Br. J. Rheumatol. 36:1997;174-177
32. Rademacher T.W., et al. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. U. S. A. 91:1994;6123-6127
33. Nordling C., et al. Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum. 35:1992;717-722
34. Koopman W.J., Gay S. The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis. Scand. J. Rheumatol. Suppl. 75:1988;284-289
35. Saso L., et al. Changes in concanavalin A-reactive proteins in neurological disorders. J. Clin. Lab. Anal. 13:1999;158-165
36. Orlacchio A., et al. Activity levels of a β1, 6 N- acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients. J. Neurol. Sci. 151:1997;177-183
37. Demetriou M., et al. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:2001;733-739
38. Quarles R.H. Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell. Mol. Life Sci. 59:2002;1851-1871
39. Delarasse C., et al. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest. 112:2003;544-553
40. Hjelmstrom P., et al. A molecular model of myelin oligodendrocyte glycoprotein. J. Neurochem. 71:1998;1742-1749
41. Johns T.G., Bernard C.C. The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72:1999;1-9
42. Schachner M. Families of neural adhesion molecules. Ciba Found. Symp. 145:1989;156-169
43. Burger D., et al. Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. J. Neurochem. 61:1993;1822-1827
44. Linares D., et al. The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice. J. Autoimmun. 21:2003;339-351
45. Slavin A.J., et al. Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev. Neurosci. 19:1997;69-78
46. Derbinski J., et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2:2001;1032-1039
47. Pagany M., et al. Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates. Neurosci. Lett. 350:2003;165-168
48. Brok H.P., et al. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J. Immunol. 165:2000;1093-1101
49. Boon L., et al. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J. Immunol. 167:2001;2942-2949
50. Confavreux C., et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N. Engl. J. Med. 339:1998;285-291
51. Grohmann U., et al. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24:2003;242-248
52. Kammerer U., et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 162:2003;887-896
53. Geijtenbeek T.B., et al. DC-SIGN, a dentritic cell-specific HIV-1 receptor present in placenta that infects T cells in trans - a review. Placenta. 22:(Suppl. A):2001;S19-S23
54. Soilleux E.J., Coleman N. Transplacental transmission of HIV: a potential role for HIV binding lectins. Int. J. Biochem. Cell Biol. 35:2003;283-287
55. Matzinger P. The danger model: a renewed sense of self. Science. 296:2002;301-305
56. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:2002;927-930
57. Engering A., et al. Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23:2002;480-485
58. Fallarino F., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:2003;1206-1212
59. Tompkins S.M., et al. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann. N. Y. Acad. Sci. 958:2002;26-38